ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11718-5mg |
|
220509-74-0 |
Caspase-3/7 Inhibitor I
|
0 | C14H16N2O5S | |
GC11718-1mg |
|
220509-74-0 |
Caspase-3/7 Inhibitor I
|
0 | C14H16N2O5S | |
GC11717-1mg |
|
112849-14-6 |
(24S)-MC 976
|
0 | C27H42O3 | |
GC11716-25mg |
|
14513-15-6 |
SIRT1/2 Inhibitor IV
|
0 | C21H16N2O2S | |
GC11716-10mg |
|
14513-15-6 |
SIRT1/2 Inhibitor IV
|
0 | C21H16N2O2S | |
GC11716-5mg |
|
14513-15-6 |
SIRT1/2 Inhibitor IV
|
0 | C21H16N2O2S | |
GC11715-5mg |
|
2552-55-8 |
Ibotenic acid
|
0 | C5H6N2O4 | |
GC11714-50mg |
|
179474-81-8 |
Prucalopride
|
0 | C18H26ClN3O3 | |
GC11714-10mg |
|
179474-81-8 |
Prucalopride
|
0 | C18H26ClN3O3 | |
GC11713-10mM (in 1mL DMSO) |
|
— |
Q-VD(OMe)-OPh
|
0 | C26H25F2N3O6 | |
GC11713-25mg |
|
— |
Q-VD(OMe)-OPh
|
0 | C26H25F2N3O6 | |
GC11713-10mg |
|
— |
Q-VD(OMe)-OPh
|
0 | C26H25F2N3O6 | |
GC11713-5mg |
|
— |
Q-VD(OMe)-OPh
|
0 | C26H25F2N3O6 | |
GC11713-1mg |
|
— |
Q-VD(OMe)-OPh
|
0 | C26H25F2N3O6 | |
GC11712-25mg |
|
134036-53-6 |
AG-370
|
0 | C15H9N5 | |
GC11712-10mg |
|
134036-53-6 |
AG-370
|
0 | C15H9N5 | |
GC11712-5mg |
|
134036-53-6 |
AG-370
|
0 | C15H9N5 | |
GC11712-1mg |
|
134036-53-6 |
AG-370
|
0 | C15H9N5 | |
GC11711-100mg |
|
1616632-77-9 |
ONC201
|
0 | C24H26N4O | |
GC11711-50mg |
|
1616632-77-9 |
ONC201
|
0 | C24H26N4O | |